Literature DB >> 10795912

Catecholaminergic mechanisms underlying neurohypophysial hormone responses to unconditioned or conditioned aversive stimuli in rats.

T Onaka1.   

Abstract

Oxytocin release from the neurohypophysis is facilitated by systemic cholecystokinin octapeptide (CCK) administration and noxious stimuli. Oxytocin release after CCK administration is mediated by A2 noradrenergic neurones while the release after noxious stimuli appears to be mediated by A1 noradrenergic neurones. On the other hand, facilitation of vasopressin release after noxious stimuli is not dependent upon noradrenergic neurones but on dopamine receptors. Environmental stimuli previously paired with noxious stimuli (conditioned fear stimuli) or novel environmental stimuli facilitate oxytocin release and suppress vasopressin release. These neuroendocrine responses to conditioned fear stimuli, but not to novel stimuli, are impaired by central noradrenaline depletion or i.c.v. adrenoceptor antagonists. These data suggest that there are at least two types of stress responses in neuroendocrine systems, one noradrenaline dependent, and one noradrenaline independent. It is also suggested that noradrenergic neurones are functionally heterogeneous in the control of oxytocin release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795912     DOI: 10.1111/j.1469-445x.2000.tb00013.x

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  3 in total

1.  Ghrelin inhibits visceral afferent activation of catecholamine neurons in the solitary tract nucleus.

Authors:  Ran Ji Cui; Xiaojun Li; Suzanne M Appleyard
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

2.  Learning strategies during fear conditioning.

Authors:  Russ E Carpenter; Cliff H Summers
Journal:  Neurobiol Learn Mem       Date:  2009-05       Impact factor: 2.877

3.  Presynaptic glutamatergic transmission and feedback system of oxytocinergic neurons in the hypothalamus of a rat model of adjuvant arthritis.

Authors:  Teruaki Fujitani; Takanori Matsuura; Makoto Kawasaki; Hitoshi Suzuki; Haruki Nishimura; Kazuhiko Baba; Yoshiaki Yamanaka; Hideo Ohnishi; Yoichi Ueta; Akinori Sakai
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.